Combo Thrombolytic Approach Fails to Reduce ICH in Stroke :

The DUMAS study showed no benefit on the primary outcome of all ICH with low-dose alteplase followed by mutant pro-urokinase; but there were promising signs of a potential reduced bleeding risk.

Related Keywords

Austria , Cambridge , Cambridgeshire , United Kingdom , Netherlands , Massachusetts , United States , Singapore , Diederik Dippel , Stefan Kiechl , National Institutes Of Health Stroke Scale , University Of Innsbruck , Thrombolytic Science , Erasmus University Medical Center , World Stroke Congress , Erasmus University Medical , National Institutes , Health Stroke Scale , Modified Rankin Scale , Medscape Cardiology , Medical University , Stroke , Erebrovascular Accident , Va Cerebrovascular Accident , Thromboembolism , Tissue Plasminogen Activator Tpa , Pa Tissue Plasminogen Activator , Ischemic Stroke , Hemorrhage , Bleeding , Thrombolytic Therapy , Intracranial Hemorrhage , Intracranial Bleeding , Traumatic Brain Injury , Bi Traumatic Brain Injury , Intracerebral Hemmorhage , Intravenous Iv , Intravenous , Tv , Maine ,